retatrutide vs tirzepatide vs semaglutide Retatrutide: 2026 Chicago Guide Retatrutide vs Semaglutide and Tirzepatide:

Even as the patent on semaglutide expires, the market may have already moved toward these superior multi-receptor agents, effectively creating a new cycle of exclusivity

Higher dose exploration (4.5mg trials) Rationale for testing 4.5mg: Investigate maximum tolerable dose Determine if higher = better weight loss Establish safety ceiling Results at 4.5mg weekly: Weight loss: ~12% (vs 10% at 2.4mg) Incremental benefit: Only 2% additional loss Side effects: Significantly worse nausea/vomiting Dropout rate: Higher than 2.4mg Clinical verdict: 4.5mg not recommended for routine use Risk-benefit ratio unfavorable 2.4mg remains optimal Some individuals may tolerate 3.0mg as compromise CagriSema combination dosing trials REDEFINE-1 protocol: Semaglutide: 2.4mg weekly (standard titration over 16 weeks) Cagrilintide: 2.4mg weekly (12-week titration) Both given as separate injections Started simultaneously from week 1 Semaglutide escalation (standard): Weeks 1-4: 0.25mg Weeks 5-8: 0.5mg Weeks 9-12: 1.0mg Weeks 13-16: 1.7mg Week 17+: 2.4mg Cagrilintide escalation (when combined): Weeks 1-4: 0.6mg Weeks 5-8: 1.2mg Weeks 9-12: 1.8mg Week 13+: 2.4mg Results: 15.6% average weight loss (68 weeks) Superior to either alone Side effects manageable with slow titration Combination well-tolerated See our cagrilintide and semaglutide combination guide and semaglutide dosage calculator

The activation of JAK2/STAT3 [163] induces the expression of the pro-fibrotic mediators TGF-1, collagen type I, IL-1, IL-6, and CCL2 particularly in Kupffer cells and sinusoidal endothelial cells [164, 165] (Fig

Utilize the Compounded Semaglutide Dosage Chart for Accurate Dosing To effectively utilize compounded semaglutide, please take a look at the dosage chart below: Week 1: 0.25 mg (10 units for insulin syringe) Week 2: 0.25 mg (10 units for insulin syringe) Week 3: 0.25 mg (10 units for insulin syringe) Week 4: 0.25 mg (10 units for insulin syringe) Week 5: 0.5 mg (20 units for insulin syringe) Week 6: 0.5 mg (20 units for insulin syringe) Week 7: 1.0 mg (40 units for insulin syringe) Week 8: 1.5 mg (60 units for insulin syringe) Week 9: 2.0 mg (80 units for insulin syringe) Week 10: 2.4 mg (96 units for insulin syringe) Start with a dose of 0.25 mg once weekly for the first four weeks